Myofascial Pain in Athletes Treatment & Management
- Author: Auri Bruno-Petrina, MD, PhD; Chief Editor: Sherwin SW Ho, MD more...
Acute Phase
Rehabilitation Program
Physical Therapy
Effective treatment of an MPS caused by TrPs usually involves more than simply applying a procedure to TrPs.[15, 5, 16] Often, it is necessary to consider and deal with the cause that activated the TrPs, to identify and correct any perpetuating factors (which often are different than what activated the TrPs), and to help the patient restore and maintain normal muscle function. Common misconceptions about the treatment of TrPs include the following:
- Simply treating the TrP should be sufficient, especially if the stress that activated the TrP is not recurrent and if no perpetuating factors are present.
- In this case, the TrP is likely to be reactivated by the same stress.
- Ignoring perpetuating factors invites recurrence. After the TrPs have persisted for some time, failure to retrain the muscle to normal function or failure to reestablish its full-stretch range of motion results in a degree of persistent motor dysfunction.
- The pain cannot be as severe as the patient says and must be largely psychogenic.
- The patients are trying to communicate their degree of pain. Believe them. The pain feels severe to them. Patients in a general medical practice rated their pain as severe as or more severe than pain from other causes such as pharyngitis, cystitis, angina, and herpes zoster.
- An appreciable amount of the pain reported by many patients with fibromyalgia comes from their TrPs. The pain of fibromyalgia rates fully as severe as the pain of rheumatoid arthritis. It is severe enough to cause central nervous system changes characteristic of chronic pain.
- Because of their chronic lip and fibromyalgia pain, these patients often develop pain behaviors that tend to reinforce dysfunction and further pain. Many patients experience grievous and needless degree and duration of pain, because a series of clinicians unacquainted with MTrPs erroneously (covertly if not overtly) diagnosed a psychogenic condition.
- MPSs are self-limiting and will cure themselves.
- An acute uncomplicated TrP activated by an unusual activity or muscle overload can revert spontaneously to a latent TrP within 1 or 2 weeks, if the muscle is not overstressed (used within tolerance, which may be limited) and if no perpetuating factors are present. Otherwise, if the acute syndrome is not properly managed, it evolves needlessly into a chronic MPS.
- Relief of pain by treatment of skeletal muscles for MTrPs rules out serious visceral disease.
- Because of the referred pain nature of visceral pain, application of Vapo coolant spray or infiltration of a local anesthetic into the somatic reference zone can temporarily relieve the pain of myocardial infarction, angina, and acute abdominal disease with no effect on the visceral pathology.
Rehabilitation program: The treatment approaches include the use of simple muscle stretch, augmented muscle stretch, post-isometric relaxation, reciprocal inhibition, slow exhalation, eye movement, TrP pressure release, massage, range of motion, heat, ultrasound, high-voltage galvanic stimulation, drug treatment, biofeedback, and new injection techniques.[4]
Physical therapy includes simple muscle stretch, augmented muscle stretch, post-isometric relaxation, reciprocal inhibition, slow exhalation, eye movement, TrP pressure release, massage, range of motion, heat, ultrasound, and high-voltage galvanic stimulation.[4, 17, 18]
Medical Issues/Complications
Table 2. Myofascial Trigger Points Mistakenly Diagnosed as Other Conditions (Open Table in a new window)
| Initial Diagnosis | TrPs |
| Angina pectoris, atypical | Pectoralis major |
| Appendicitis | Lower rectus abdominis |
| Atypical facial neuralgia | Masseter, temporalis, sternal division of the sternocleidomastoid, upper trapezius |
| Atypical migraine | Sternocleidomastoid, temporalis, posterior cervical |
| Back pain, middle | Upper rectus abdominis, thoracic paraspinals |
| Back pain, low | Lower rectus abdominis, thoracolumbar paraspinals |
| Bicipital tendinitis | Long head of the biceps brachii |
| Chronic abdominal wall pain | Abdominal muscles |
| Dysmenorrhea | Lower rectus abdominis |
| Earache, enigmatic | Deep masseter |
| Epicondylitis | Wrist extensors, supinator, triceps brachii |
| Frozen shoulder | Subscapularis |
| Myofascial pain dysfunction | Masticatory muscles |
| Occipital headache | Posterior cervicals |
| Post-therapeutic neuralgia | Serratus anterior, intercostals |
| Radiculopathy, C6 | Pectoralis minor, scalenes |
| Scapulocostal syndrome | Scalenes, middle trapezius, levator scapulae |
| Subacromial bursitis | Middle deltoid |
| Temporomandibular joint disorder | Masseter, lateral pterygoid |
| Tennis elbow | Finger extensors, supinator |
| Tension headache | Sternocleidomastoid, masticatory, posterior cervicals, suboccipital, upper trapezius |
| Thoracic outlet syndrome | Scalenes, subscapularis, pectoralis minor and major, latissimus dorsi, teres major |
Table 3. Differences in Clinical Features that Distinguish Myofascial Pain due to TrPs from Fibromyalgia (Open Table in a new window)
| Feature | Myofascial Pain (TrPs) | Fibromyalgia |
| Female-to-male ratio | 1:1 | 4-9:1 |
| Pain | Local or regional | Widespread, general |
| Tenderness | Focal | Widespread |
| Muscle | Feels tense (taut bands) | Feels soft and doughy |
| Motion | Restricted range of motion | Hypermobility |
| Examination | Examine for TrPs | Examine for tender points |
- Complications of injections
- Pneumothorax by aiming the needle at an intercostal space: The only exception is when the intercostal muscles must be injected. This should be performed with great care.
- The location of the needle tip can be misjudged readily when using a long slender needle. Furthermore, the needle should be inserted straight, avoiding any side pressure that might bend it, deflecting the tip an unknown distance to one side.
- It is especially important to avoid using a needle with a burr at the tip because it causes unnecessary bleeding. When the tip of a disposable needle contacts bone, the impact frequently curls the tip to produce a fishhook burr that feels scratchy and drags as the needle is drawn through tissues.
- Contraindications to TrP injections
- Patients on anticoagulation therapy
- If the patient has taken aspirin within 3 days of injection
- Tobacco smokers, unless they have stopped smoking and have taken at least 500 mg of timed-release vitamin C for 3 days prior to injection
- Patients who have an inordinate fear of needles
- Patients should avoid strenuous activity and sports for 10 days.
Consultations
The clinical importance of MTrPs to practitioners has been described in the literature for acupuncturists, anesthesiologists, chronic pain managers, dentists, family practitioners, gynecologists, neurologists, nurses, orthopedic surgeons, pediatricians, physical therapists, physiatrists, rheumatologists, and veterinarians.
Other Treatment
Infants have been observed with point tenderness of the rectus abdominis muscle and colic, both of which were relieved by sweeping a stream of Vapo coolant over the muscle, which helps to inactivate MTrPs.
The clinical effectiveness of botulinum A toxin injection for the treatment of MTrPs helps to substantiate dysfunctional endplates as an essential part of the pathophysiology of TrPs (see the images below).[19, 20, 21] This toxin specifically acts only on the neuromuscular junction, effectively denervating that muscle cell.[22]
Myofascial pain in athletes. Mechanism of botulinum toxin type A.
Myofascial pain in athletes. Binding of neuromuscular transmission with botulinum toxin type A, which binds the motor nerve terminal.
Myofascial pain in athletes. After botulinum toxin type A is internalized, the light chain of the toxin molecule is released into the cytoplasm of the nerve terminal.
Myofascial pain in athletes. Botulinum toxin type A blocks acetylcholine by cleaving a cytoplasmic protein on the cell membrane.
Myofascial pain in athletes. After the botulinum toxin type A exerts its clinical toxic effect, a nerve sprout eventually establishes a new neuromuscular junction, and muscle activity gradually returns. However, new research findings suggest that this new nerve sprout retracts and the original junction returns to functionality.
Myofascial pain in athletes. After the clinical toxic effect of botulinum toxin type A occurs, axon sprouting and muscle fiber reinnervation terminate the clinical effect of the toxin, which results in the reestablishment of neuromuscular transmission. - Sequence of steps when stretching and spraying any muscle for MTrPs (see the image below)[23]
Myofascial pain in athletes. Sequence of steps to use when stretching and spraying any muscle for myofascial trigger points. - The patient is supported in a comfortable relaxed position.
- One end of the muscle is anchored.
- Skin is sprayed with repeated parallel sweeps of the Vapo coolant over the length of the muscle in the direction of pain pattern.
- After the first sweep of spray, pressure is applied to take up the slack in the muscle and is continued as additional sweeps of spray are applied.
- Sweeps of the spray are extended to cover the referred pain pattern.
- Steps 3, 4, and 5 may be repeated 2 or 3 times until the skin becomes cold to the touch or when the range of motion reaches maximum.
- Technique of spray and stretch
- For example, treatment for right levator scapulae TrPs; the direction and pattern of the Vapo coolant spray follows the muscle fibers (see the image below).
Myofascial pain in athletes. Schematic drawing showing how the jet stream of Vapo coolant is applied. - During the distraction of the spray, the operator presses the patient's head forward and to the opposite side, while using the elbow to press the patient's shoulder down and back. Similar techniques are applied to most other TrPs. The key ingredient is the prolonged stretch of the affected muscle.
- Unidirectional sweeps cover, first, parallel lines of skin over those muscle fibers that are stretched the tightest, then over the rest of the muscle and its pain pattern. Sequential sweeps of spray should follow the direction of the muscle fibers and progress toward the referred pain zone.
- For example, treatment for right levator scapulae TrPs; the direction and pattern of the Vapo coolant spray follows the muscle fibers (see the image below).
- TrP injection
- To prevent bleeding, the fingers of the palpating hand should be spread apart, maintaining tension on the skin to reduce the likelihood of subcutaneous bleeding where the needle has penetrated (see the image below). Also, during the injection, the fingers exert pressure around the needle tip to provide homeostasis in deeper tissues. When the angle of the needle is changed, the direction of pressure changes.
Myofascial pain in athletes. Schematic top view of 2 approaches to the flat injection of a trigger point area in a palpable taut band. Injection away from the fingers (A) and injection toward the fingers (B). - The physician should avoid inserting the needle to the hub where the needle is most likely to break off. Some additional depth of penetration can be obtained safely by indenting the skin and subcutaneous tissues with a finger beside the needle as illustrated in the image below.
Myofascial pain in athletes. C. Z. Hong's technique. Finger pressure beside the needle is used to indent the skin, subcutaneous, and fat tissues so that the needle can reach the trigger point in a muscle that would be inaccessible otherwise. - The importance of distinguishing between central TrPs, ie, in the central portion of the muscle belly and attachment TrPs when injecting, is illustrated in the image below.
Myofascial pain in athletes. Diagrammatic representation of pre-injection sites (open circles) and injection sites (solid circles) of local anesthetic to the trigger point. The enclosed stippled area represents the taut band. This diagram distinguishes the central trigger point within the large broken circle from the attachment trigger points located at the myotendinous junction and at the attachment of the tendon to the bone. Each of these 3 trigger point regions can be identified by their individual spot tenderness and anatomical locations. No rationale is apparent for injecting the part of the taut band that lies between the central trigger point and the attachment trigger point (solid circles numbers 7-10).
- To prevent bleeding, the fingers of the palpating hand should be spread apart, maintaining tension on the skin to reduce the likelihood of subcutaneous bleeding where the needle has penetrated (see the image below). Also, during the injection, the fingers exert pressure around the needle tip to provide homeostasis in deeper tissues. When the angle of the needle is changed, the direction of pressure changes.
- The increased capillary fragility characteristic of a low serum vitamin C level can cause excessive bleeding in muscles injected for TrPs. Capillary hemorrhage augments postinjection soreness and leads to unsightly ecchymoses. A frequent source of increased bleeding due to low vitamin C is tobacco. Mega-dose vitamin C therapy daily for 1 week should correct this deficiency. At least 500 mg of timed-release vitamin C 3 times daily is recommended for a minimum of 3 days prior to injection of TrPs. A daily dose of aspirin increases the susceptibility to bleeding. The patient should take no aspirin for 3 days before TrP injection or needling.[24]
Recovery Phase
Rehabilitation Program
Physical Therapy
See Acute Phase Physical Therapy.
Occupational Therapy
See Acute Phase Physical Therapy.
Simons DG, Mense S. [Diagnosis and therapy of myofascial trigger points]. Schmerz. Dec 2003;17(6):419-24.
Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. Baltimore, Md: Lippincott Williams & Wilkins; 1983.
Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. Upper half of Body. Vol 1. 2nd ed. Baltimore, Md: Lippincott Williams & Wilkins; 1999.
Fisher AA. Diagnosis and management of chronic pain in physical medicine and rehabilitation. In: Ruskin AP, ed. Current Therapy in Physiatry. Philadelphia, Pa: WB Saunders Co; 1984:123-154.
Thompson JM. The diagnosis and treatment of muscle pain syndromes. In: Braddom RL, ed. Physical Medicine and Rehabilitation. Philadelphia, Pa: WB Saunders Co; 1996.
Schneider MJ. Tender points/fibromyalgia vs. trigger points/myofascial pain syndrome: a need for clarity in terminology and differential diagnosis. J Manipulative Physiol Ther. Jul-Aug 1995;18(6):398-406. [Medline].
Simons AG. Muscular pain syndromes. In: Fricton JR, Awad FA, eds. Advances in Pain Research and Therapy. Myofascial Pain and Fibromyalgia. Vol 17. New York, NY: Raven Press; 1990:18.
Rosen NB. Myofascial pain: the great mimicker and potentiator of other diseases in the performing artist. Md Med J. Mar 1993;42(3):261-6. [Medline].
Lambert CM. Hand and upper limb problems of instrumental musicians. Br J Rheumatol. Apr 1992;31(4):265-71. [Medline].
Charness ME, Parry GJ, Markison RE, et al. Entrapment neuropathies in musicians. Neurology. 1985;35(suppl 1):74.
Lederman RJ. Nerve entrapment syndromes in instrumental musicians. Med Probl Perform Art. 1986;1:45-8.
Maffulli N, Maffulli F. Transient entrapment neuropathy of the posterior interosseous nerve in violin players. J Neurol Neurosurg Psychiatry. Jan 1991;54(1):65-7. [Medline].
Ballyns JJ, Shah JP, Hammond J, Gebreab T, Gerber LH, Sikdar S. Objective sonographic measures for characterizing myofascial trigger points associated with cervical pain. J Ultrasound Med. Oct 2011;30(10):1331-40. [Medline].
Hubbard DR, Berkoff GM. Myofascial trigger points show spontaneous needle EMG activity. Spine. Oct 1 1993;18(13):1803-7. [Medline].
Hong CZ. Treatment of myofascial pain syndrome. Curr Pain Headache Rep. Oct/2006;5:345-9.
Walsh NE, Dimitru D, Schoenfeld LS, Ramamurthy S. Treatment of the patient with chronic pain. In: DeLisa JA, ed. Rehabilitation Medicine: Principles and Practice. 3rd ed. Philadelphia, Pa: Lippincott-Raven; 1998.
Sarrafzadeh J, Ahmadi A, Yassin M. The Effects of Pressure Release, Phonophoresis of Hydrocortisone, and Ultrasound on Upper Trapezius Latent Myofascial Trigger Point. Arch Phys Med Rehabil. Oct 7 2011;[Medline].
Rha DW, Shin JC, Kim YK, Jung JH, Kim YU, Lee SC. Detecting local twitch responses of myofascial trigger points in the lower-back muscles using ultrasonography. Arch Phys Med Rehabil. Oct 2011;92(10):1576-1580.e1. [Medline].
Acquadro MA, Borodic GE. Treatment of myofascial pain with botulinum A toxin. Anesthesiology. Mar 1994;80(3):705-6. [Medline].
Cheshire WP, Abashian SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain. Oct 1994;59(1):65-9. [Medline].
Scott AB. Forward. In: Jankovic J, Hallet M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker Inc; 1994:vii-ix.
Coffield JA, Considine RV, Simpson LL. The site and mechanism of action of botulinum neurotoxin. In: Jankovic J, Hallet M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker Inc; 1994:3-13.
Travell JG. Ethylchloride spray for painful muscle spasm. Arch Phys Med Rehabil. 1952;33:291-8.
Huang YT, Lin SY, Neoh CA, Wang KY, Jean YH, Shi HY. Dry needling for myofascial pain: prognostic factors. J Altern Complement Med. Aug 2011;17(8):755-62. [Medline].
Annaswamy TM, De Luigi AJ, O'Neill BJ, Keole N, Berbrayer D. Emerging Concepts in the Treatment of Myofascial Pain: A Review of Medications, Modalities, and Needle-based Interventions. PM R. Oct 2011;3(10):940-61. [Medline].
Gregory PL, Biswas AC, Batt ME. Musculoskeletal problems of the chest wall in athletes. Sports Med. 2002;4:235-50.
Gregory PL, Biswas AC, Batt ME. Musculoskeletal problems of the chest wall in athletes. Sports Med. 2002;32(4):235-50.
Fredericson M, Weir A. Practical management of iliotibial band friction syndrome in runners. Clin J Sport Med. May 2006;3:261-8.
Fredericson M, Weir A. Practical management of iliotibial band friction syndrome in runners. Clin J Sport Med. May 2006;16(3):261-8.
Hatheway CL, Dang C. Immunogenicity of the neurotoxins of Clostridium botulinum. In: Jankovic J, Hallet M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker; 1994:93-107.
Hong CZ. Treatment of myofascial pain syndrome. Curr Pain Headache Rep. Oct 2006;10(5):345-9.
Reiter RC, Gambone JC. Nongynecologic somatic pathology in women with chronic pelvic pain and negative laparoscopy. J Reprod Med. Apr 1991;36(4):253-9. [Medline].
Wainapel SF, Cole IL. The not so magic flute: two cases of distal ullnar nerve entrapment. Med Probl Perform Art. 1988;3:63-5.
| Region | Practice | Number Studied | Prevalence of Myofascial Pain, % |
| General | Medical | 172 | 30 |
| General | Pain medical center | 96 | 93 |
| General | Comprehensive pain center | 283 | 85 |
| Craniofacial | Head and neck pain clinic | 164 | 55 |
| Lumbogluteal | Orthopedic clinic | 97 | 21 |
| Initial Diagnosis | TrPs |
| Angina pectoris, atypical | Pectoralis major |
| Appendicitis | Lower rectus abdominis |
| Atypical facial neuralgia | Masseter, temporalis, sternal division of the sternocleidomastoid, upper trapezius |
| Atypical migraine | Sternocleidomastoid, temporalis, posterior cervical |
| Back pain, middle | Upper rectus abdominis, thoracic paraspinals |
| Back pain, low | Lower rectus abdominis, thoracolumbar paraspinals |
| Bicipital tendinitis | Long head of the biceps brachii |
| Chronic abdominal wall pain | Abdominal muscles |
| Dysmenorrhea | Lower rectus abdominis |
| Earache, enigmatic | Deep masseter |
| Epicondylitis | Wrist extensors, supinator, triceps brachii |
| Frozen shoulder | Subscapularis |
| Myofascial pain dysfunction | Masticatory muscles |
| Occipital headache | Posterior cervicals |
| Post-therapeutic neuralgia | Serratus anterior, intercostals |
| Radiculopathy, C6 | Pectoralis minor, scalenes |
| Scapulocostal syndrome | Scalenes, middle trapezius, levator scapulae |
| Subacromial bursitis | Middle deltoid |
| Temporomandibular joint disorder | Masseter, lateral pterygoid |
| Tennis elbow | Finger extensors, supinator |
| Tension headache | Sternocleidomastoid, masticatory, posterior cervicals, suboccipital, upper trapezius |
| Thoracic outlet syndrome | Scalenes, subscapularis, pectoralis minor and major, latissimus dorsi, teres major |
| Feature | Myofascial Pain (TrPs) | Fibromyalgia |
| Female-to-male ratio | 1:1 | 4-9:1 |
| Pain | Local or regional | Widespread, general |
| Tenderness | Focal | Widespread |
| Muscle | Feels tense (taut bands) | Feels soft and doughy |
| Motion | Restricted range of motion | Hypermobility |
| Examination | Examine for TrPs | Examine for tender points |

